Glover Stephen C.
Transactions
50
Companies
8
Filings
12
CIK
0001304406
Recent Transactions
- Award
- Award
- Award
- Award
- Purchase
- Purchase
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Purchase
- Award
- Award
- Award
- Exercise/Conversion
- Award
- Tax Payment
- Disposition to Issuer
- Exercise/Conversion
- Award
- Award
- Award
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
Companies
8ANDRX CORP /DE/
SVP Brand Operations
AURIGA LABORATORIES, INC.
Director
Ambrx Biopharma Cayman, Inc.
Director
Ambrx Biopharma, Inc.
Director
- $INSM
INSMED Inc
President Follow-on Biologics
- $ONCY
ONCOLYTICS BIOTECH INC
Director
- $PDSB
PDS Biotechnology Corp
Director
- $ZVSA
ZyVersa Therapeutics, Inc.
Director, Chief Executive Officer
Recent Filings
12- 4
Glover Stephen C.
Jun 3, 2026
- 4
Glover Stephen C.
Mar 3, 2026
- 4
Glover Stephen C.
Jul 15, 2025
- 4
Glover Stephen C.
Jun 11, 2025
- 4
Glover Stephen C.
Mar 3, 2025
- 4
Glover Stephen C.
Jul 18, 2024
- 4
Glover Stephen C.
Jun 25, 2024
- 4
Glover Stephen C.
Mar 7, 2024
- 4
Glover Stephen C.
Jul 17, 2023
- 4
Glover Stephen C.
Jun 9, 2023
- 4
Glover Stephen C.
May 26, 2023
- 4
Glover Stephen C.
Dec 14, 2022
Address
C/O ONCOLYTICS BIOTECH INC. 4350 EXECUTIVE DRIVE, SUITE 325
SAN DIEGO, CA, 92121